Natixis’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-11,682
| Closed | -$2.94M | – | 1281 |
|
|
2022
Q3 | $2.94M | Buy |
11,682
+217
| +2% | +$54.6K | 0.01% | 497 |
|
|
2022
Q2 | $2.87M | Sell |
11,465
-538
| -4% | -$135K | 0.01% | 550 |
|
|
2022
Q1 | $3.98M | Sell |
12,003
-3,493
| -23% | -$1.16M | 0.01% | 603 |
|
|
2021
Q4 | $5.57M | Buy |
15,496
+2,625
| +20% | +$943K | 0.02% | 530 |
|
|
2021
Q3 | $4.19M | Sell |
12,871
-19,431
| -60% | -$6.33M | 0.01% | 586 |
|
|
2021
Q2 | $10.1M | Sell |
32,302
-11,866
| -27% | -$3.7M | 0.04% | 275 |
|
|
2021
Q1 | $14.1M | Sell |
44,168
-4,373
| -9% | -$1.39M | 0.05% | 320 |
|
|
2020
Q4 | $15.7M | Buy |
+48,541
| New | +$15.7M | 0.06% | 302 |
|
|
2020
Q3 | – | Sell |
-16,191
| Closed | -$3.91M | – | 903 |
|
|
2020
Q2 | $3.91M | Sell |
16,191
-6,403
| -28% | -$1.55M | 0.03% | 333 |
|
|
2020
Q1 | $3.28M | Sell |
22,594
-4,440
| -16% | -$645K | 0.03% | 319 |
|
|
2019
Q4 | $4.52M | Buy |
27,034
+2,452
| +10% | +$410K | 0.03% | 419 |
|
|
2019
Q3 | $4.37M | Buy |
+24,582
| New | +$4.37M | 0.03% | 375 |
|
|
2019
Q2 | – | Sell |
-29,183
| Closed | -$8.29M | – | 935 |
|
|
2019
Q1 | $8.29M | Buy |
+29,183
| New | +$8.29M | 0.05% | 303 |
|
|
2018
Q3 | – | Sell |
-66,363
| Closed | -$27.1M | – | 1010 |
|
|
2018
Q2 | $27.1M | Buy |
66,363
+38,854
| +141% | +$15.9M | 0.14% | 153 |
|
|
2018
Q1 | $8.01M | Buy |
27,509
+11,721
| +74% | +$3.41M | 0.05% | 287 |
|
|
2017
Q4 | $2.96M | Buy |
15,788
+1,983
| +14% | +$372K | 0.02% | 362 |
|
|
2017
Q3 | $2.33M | Buy |
+13,805
| New | +$2.33M | 0.02% | 388 |
|
|
2017
Q2 | – | Sell |
-7,113
| Closed | -$891K | – | 1019 |
|
|
2017
Q1 | $891K | Buy |
+7,113
| New | +$891K | 0.01% | 412 |
|